GLP-1 Impact On Healthcare Demand Is Soaring

See how demand for medications for type 2 diabetes and chronic weight management is projected to reduce demand for multiple therapeutic areas by 2033. Glucagon-like peptide-1 (GLP-1) receptor agonists mimic the natural GLP-1 hormone, which regulates blood sugar, rate of stomach emptying, and signals of fullness to the brain.

Already A HIDA Member? Sign In
HIDA Member Access Includes:
  • The online Member Directory
  • Government Affairs Alerts, FAQs and briefings
  • HIDA Research Chartbooks
  • The HIDA Learning Center

That's just what's online. Check out all the benefits of membership today.

Learn More
Anticipate shifts, reduce risk, and decide with confidence — powered by actionable intelligence from the HIDA Knowledge Center.